A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Safety, Tolerability and Pharmacokinetics of Various Doses of KP001 (Epinephrine Inhalation Aerosol) in Healthy Adult Volunteers While Assessing Carryover Effects
Latest Information Update: 26 May 2025
At a glance
- Drugs ART-001 (Primary)
- Indications Anaphylaxis; Hypersensitivity
- Focus Pharmacokinetics
Most Recent Events
- 26 May 2025 New trial record